DAVID POPLACK to Female
This is a "connection" page, showing publications DAVID POPLACK has written about Female.
Connection Strength
0.140
-
An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110.
Score: 0.006
-
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72.
Score: 0.005
-
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor. J Clin Oncol. 1993 Sep; 11(9):1795-803.
Score: 0.004
-
Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst. 1993 Jun 16; 85(12):993-6.
Score: 0.004
-
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 01; 53(5):1032-6.
Score: 0.004
-
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 01; 52(3):521-4.
Score: 0.004
-
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991 Nov 15; 51(22):6079-83.
Score: 0.004
-
Increasing diversity in pediatric hematology/oncology. Pediatr Blood Cancer. 2011 Jul 15; 57(1):147-52.
Score: 0.004
-
Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 1990 Dec 15; 50(24):7915-9.
Score: 0.004
-
Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas. Invest New Drugs. 1990 May; 8(2):181-2.
Score: 0.003
-
Phase I trial and pharmacokinetic evaluation of fazarabine in children. Cancer Res. 1989 Sep 15; 49(18):5213-6.
Score: 0.003
-
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr. 1989 May; 114(5):880-4.
Score: 0.003
-
The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med. 1989 Feb 15; 110(4):279-85.
Score: 0.003
-
Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol. 1988 Dec; 6(12):1882-6.
Score: 0.003
-
Bioavailability of low-dose vs high-dose 6-mercaptopurine. Clin Pharmacol Ther. 1988 May; 43(5):588-91.
Score: 0.003
-
A pediatric phase I and pharmacokinetic study of spirohydantoin mustard. Cancer Res. 1988 Apr 15; 48(8):2292-5.
Score: 0.003
-
The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther. 1987 Apr; 41(4):384-7.
Score: 0.003
-
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504.
Score: 0.003
-
Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia. Cancer Res. 1986 Mar; 46(3):1495-8.
Score: 0.003
-
Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1985 Jun; 32(3):669-97.
Score: 0.002
-
Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma. Am J Clin Oncol. 1985 Jun; 8(3):210-4.
Score: 0.002
-
Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. J Pediatr. 1985 May; 106(5):723-8.
Score: 0.002
-
Remission induction of meningeal leukemia with high-dose intravenous methotrexate. J Clin Oncol. 1985 Apr; 3(4):485-9.
Score: 0.002
-
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9.
Score: 0.002
-
Acute megakaryoblastic leukemia in childhood. Cancer. 1984 Oct 01; 54(7):1423-8.
Score: 0.002
-
Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther. 1984 Jun; 35(6):826-30.
Score: 0.002
-
Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr. 1984 Feb; 104(2):182-6.
Score: 0.002
-
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med. 1983 Apr 28; 308(17):1005-9.
Score: 0.002
-
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 01; 21(1):143-7.
Score: 0.002
-
Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. Cancer Res. 1982 Sep; 42(9):3884-6.
Score: 0.002
-
Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement. Science. 1982 Jul 16; 217(4556):259-61.
Score: 0.002
-
Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 1):4508-11.
Score: 0.002
-
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Cancer Res. 1981 Sep; 41(9 Pt 1):3343-6.
Score: 0.002
-
Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec; 69(6):828-32.
Score: 0.002
-
Current concepts. Biochemical markers in lymphoid malignancy. N Engl J Med. 1980 Oct 16; 303(16):918-22.
Score: 0.002
-
Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia. Cancer. 1980 Jun 15; 45(12):3090-4.
Score: 0.002
-
Delayed allergic reactions following intramuscular L-asparaginase. Med Pediatr Oncol. 1980; 8(2):123-5.
Score: 0.002
-
Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979 Mar 24; 1(8117):630-3.
Score: 0.002
-
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6.
Score: 0.002
-
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood. 1998 Nov 15; 92(10):3569-77.
Score: 0.002
-
Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. Blood. 1978 Nov; 52(5):1033-6.
Score: 0.002
-
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60.
Score: 0.001
-
Characteristics of long-term survivors in AML. Med Pediatr Oncol. 1978; 5(1):219-23.
Score: 0.001
-
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. J Clin Oncol. 1998 Jan; 16(1):181-6.
Score: 0.001
-
A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. Clin Cancer Res. 1997 May; 3(5):713-7.
Score: 0.001
-
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43.
Score: 0.001
-
Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 1996 Aug 01; 78(3):527-31.
Score: 0.001
-
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. J Clin Oncol. 1996 Mar; 14(3):774-82.
Score: 0.001
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.001
-
Candida arthritis treated with amphotericin B. J Pediatr. 1975 Dec; 87(6 Pt 1):989-90.
Score: 0.001
-
Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma. Med Pediatr Oncol. 1995 Jun; 24(6):362-7.
Score: 0.001
-
Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. J Clin Oncol. 1995 Jan; 13(1):177-9.
Score: 0.001
-
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion. J Natl Cancer Inst. 1994 Jan 19; 86(2):143-5.
Score: 0.001
-
Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis. 1993 Dec; 168(6):1380-6.
Score: 0.001
-
Phase I/pharmacokinetic reevaluation of thioTEPA. Cancer Res. 1991 Jun 15; 51(12):3171-6.
Score: 0.001
-
Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinol (Copenh). 1991 Apr; 124(4):375-80.
Score: 0.001
-
Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr. 1990 Dec; 117(6):980-5.
Score: 0.001
-
[Infectious complications from intraventricular route of administration in cancer patients]. Probl Med Wieku Rozwoj. 1990; 16:45-53.
Score: 0.001
-
Infectious complications of intraventricular reservoirs in cancer patients. Pediatr Infect Dis J. 1987 Feb; 6(2):182-9.
Score: 0.001
-
Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1986; 3(4):319-24.
Score: 0.001
-
Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse. J Clin Oncol. 1985 Jan; 3(1):19-24.
Score: 0.001
-
Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). J Clin Neuropsychol. 1984 Aug; 6(3):325-36.
Score: 0.001
-
Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5.
Score: 0.001
-
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200.
Score: 0.000
-
Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4.
Score: 0.000
-
Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest. 1978 Sep; 62(3):710-2.
Score: 0.000
-
Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma. J Pediatr. 1978 May; 92(5):849-50.
Score: 0.000
-
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood. 1978 May; 51(5):835-42.
Score: 0.000
-
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer. 1978 Mar; 41(3):1059-63.
Score: 0.000
-
Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma. Cancer Treat Rep. 1978 Feb; 62(2):247-50.
Score: 0.000
-
Meningeal relapse of orbital rhabdomyosarcoma. Med Pediatr Oncol. 1978; 4(3):247-51.
Score: 0.000
-
Computer assisted tomography in methotrexate encephalopathy. J Comput Assist Tomogr. 1977 Apr; 1(2):216-21.
Score: 0.000
-
Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy. Cancer. 1977 Jan; 39(1):58-61.
Score: 0.000
-
Reversible dementia temporally associated with intraventricular therapy with methotrexate in a child with acute myelogenous leukemia. J Pediatr. 1976 Jan; 88(1):131-3.
Score: 0.000